BCAXBicara Therapeutics Inc.
$17.50+68% 1Y
$17.50
$10.5052 weeks$28.86
The financials
Bicara Therapeutics Inc. by the numbers
The next results filing is expected around Nov 9, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$60M | −$32M | n/a |
| Net income | −$55M | −$27M | n/a |
| Diluted EPS | −$0.82 | −$0.50 | n/a |
On our screens:Most shorted stocks
Biotechnology
The closest names by size in the same industry